HELEN OF TROY LTD
Helen of Troy is a global consumer products company that sells products under owned and licensed brands, including OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon and Olive & June. It operates two segments. Home & Outdoor offers home, beverageware, food storage, outdoor, travel and lifestyle products. Beauty & Wellness sells hair tools and hair care products, nail care products, grooming tools, thermometers, humidifiers, water and air purifiers, heaters and fans. Helen of Troy sells primarily through online and brick-and-mortar retailers, distributors and other retail channels, as well as directly to consumers. It markets products in approximately 100 countries. The company is headquartered in El Paso, Texas.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $HELE in the last 30 days.
See all $HELE insider activity →Spectrum Brands Holdings, Inc. (SPB) filed an SEC Form 8-K — Other Events. Exhibit 99.1 EMPOWER BRANDS ANNOUNCES PROPOSAL TO ACQUIRE HELEN OF TROY LTD. FOR $37.00 PER SHARE IN CASH Proposal Represents Immediate, Compelling Cash Premium of 31% Over HELE’s 30-Day Volume-Weighted Share Price The Transaction Offers Value Certainty for HELE’s Shareholders; N
Empower Brands, owned by Spectrum Brands (SPB) and Oaktree, proposed to acquire Helen of Troy (HELE) for $37 per share, a 28% premium over its October 30, 2026 closing price. The deal values Helen of Troy at $1.6 billion and would create a company with $2.9 billion in annual revenue. Helen of Troy previously rejected a lower offer. The transaction requires shareholder and regulatory approvals.
Canaccord Genuity kept a Hold rating on Helen Of Troy with a $26 price target, suggesting a 2.1% downside from the last close. The firm noted strong growth in the Home & Outdoor segment but declines in Beauty & Wellness, with a cautious outlook for Hydro Flask due to market competition.
Over the past 7 days, AlphAI's AI scored 5 news stories mentioning HELE (HELEN OF TROY LTD). Coverage has skewed bullish: 5 bullish, 0 neutral, and 0 bearish.
Recent HELE coverage spans earnings, mergers & acquisitions and financial news.
The bid could drive HELE shares higher on the premium, while SPB may face dilution risk.
The bid is likely to lift Helen of Troy shares as investors price in the premium and potential deal upside.
Analyst price target below current price suggests modest downside pressure.
Guidance above market expectations could lift the stock, while the leverage target signals financial discipline.
Improved outlook may lift the stock.
AlphAI scores every news story that mentions HELE with an AI model for sentiment and relevance, and aggregates insider trades from HELEN OF TROY LTD's SEC EDGAR Form 4 filings. Figures refresh continuously.
Spectrum Brands Holdings, Inc. (SPB) filed an SEC Form 8-K — Other Events. Exhibit 99.1 EMPOWER BRANDS ANNOUNCES PROPOSAL TO ACQUIRE HELEN OF TROY LTD. FOR $37.00 PER SHARE IN CASH Proposal Represents Immediate, Compelling Cash Premium of 31% Over HELE’s 30-Day Volume-Weighted Share Price The Transaction Offers Value Certainty for HELE’s Shareholders; N
2 min readEmpower Brands, owned by Spectrum Brands (SPB) and Oaktree, proposed to acquire Helen of Troy (HELE) for $37 per share, a 28% premium over its October 30, 2026 closing price. The deal values Helen of Troy at $1.6 billion and would create a company with $2.9 billion in annual revenue. Helen of Troy previously rejected a lower offer. The transaction requires shareholder and regulatory approvals.
2 min readCanaccord Genuity kept a Hold rating on Helen Of Troy with a $26 price target, suggesting a 2.1% downside from the last close. The firm noted strong growth in the Home & Outdoor segment but declines in Beauty & Wellness, with a cautious outlook for Hydro Flask due to market competition.
1 min readHelen of Troy Limited (HELE) projects fiscal 2027 adjusted EPS of $3.60 to $4.15 and aims for a net leverage ratio of 2.7x or lower. The company plans to reinvest tariff refunds.
1 min readLevi's (LEVI) shares fell 3.7% after softer DTC sales growth, though earnings beat estimates. Starbucks (SBUX) dropped 3% amid takeover speculation. Argenx (ARGX) fell 15% after discontinuing a drug trial. Haemonetics (HAE) rose 13% on CSL's device rollout plan. Tilray (TLRY) reported record revenue. Wolfspeed (WOLF) gained 11% on a $1.5B US DoD loan. Palantir (PLTR) rose 3% after a Goldman upgrade. Globalfoundries (GFS) rose 3% on a $2B TSMC deal. Helen of Troy (HELE) raised its profit outlook.
3 min readHelen of Troy (NASDAQ:HELE) shares rose 8.3% in pre-market trading after Q2 earnings beat estimates ($0.79 vs. $0.51) and raised FY2027 guidance. Revenue grew 2.1% YoY to $440.9M, missing estimates. Home & Outdoor segment grew, while Beauty & Wellness declined. Management cited margin expansion and tariff refunds.
2 min readHELEN OF TROY LTD (HELE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Helen of Troy Reports Second Quarter Fiscal 2027 Results Consolidated Net Sales Growth of 2.1% GAAP Net Income of $4.6 Million; Diluted EPS of $0.19 Adjusted Income (1) of $19.0 Million; Adjusted Diluted EPS (1) of $0.79 Cash Flow From Operations of $57.1 Million; Ad
3 min readCanaccord raised Helen of Troy's (HELE) price target to $26.00, citing sales recovery and expected growth in home & outdoor and Beauty & Wellness segments. The stock trades at $25.64, below InvestingPro’s Fair Value estimate. The firm anticipates gross margin improvements and higher SG&A expenses due to investments. HELE reported Q1 fiscal 2027 earnings of $0.17 per share, beating expectations, and raised its full-year revenue outlook.
2 min readUBS reiterated a Neutral rating on Helen of Troy (HELE) with a $28 price target, citing mixed investor sentiment despite the stock's 110% surge over six months. UBS expects healthy top-line growth in the first half but anticipates challenges in the second half. Helen of Troy recently reported better-than-expected Q1 earnings and raised its fiscal 2027 revenue outlook. The stock is currently trading at $29.12.
1 min readU.S. stocks initially rose, with the Dow up 150 points, driven by strong earnings, including Morgan Stanley's Q2 EPS of $3.46 vs. estimates of $2.91. Later, markets reversed, with the Dow down 0.95%. European and Asian markets showed mixed performance. Commodities saw oil rise 5.6%, while gold and silver fell. Economic data included a rise in the Empire State manufacturing index and a decline in mortgage applications.
2 min read
